Implanet S.A. (FRA:IM11)

Market Cap	29.77M +127.5%
Revenue (ttm)	12.47M +32.6%
Net Income	-4.38M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,198
Open	0.2030
Previous Close	0.1986
Day's Range	0.2030 - 0.2030
52-Week Range	0.0768 - 0.4280
Beta	n/a
RSI	45.21
Earnings Date	Sep 15, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The co...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2006
• Employees: 46
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IM11

Financial Performance

In 2025, Implanet's revenue was 12.47 million, an increase of 32.62% compared to the previous year's 9.41 million. Losses were -4.38 million, 0.37% more than in 2024.